Recent Finacing
Recent Raise
CXL Ophthalmics is a clinical-stage company developing EpiSmart, an epithelium-preserving, minimally invasive simultaneous bilateral UV corneal cross-linking system for tomographically diagnosed keratoconus, advancing to Phase 3 and NDA.
